Comparison of relieving post-needling soreness with repetitive peripheral magnetic stimulation (rPMS) compared with sham

Phase 4

• Conditions: myofascial pain trigger point at the upper trapezius muscle; myofascial pain syndrome, dry needling, acupuncture, trigger point, office syndrome, post-needling soreness, peripheral magnetic stimulation

• Registration Number: TCTR20230713013
• Lead Sponsor: Panyananthaphikkhu Chonprathan Medical Center Srinakharinwirot University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-07-13
• Study Completion: 2024-03-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

1. Patients with myofascial pain syndrome of the upper trapezius muscle with at least one myofascial pain trigger point treated by Deep Dry Needling Muscle and twitching were recorded using ultrasound and recorded in the form of a video clip.
2. Body mass index 19 to 25 kg/m2.

Exclusion Criteria

1. Patients with metal magnets within the head or treatment area within 30 cm, such as sutures, clips, coils, magnetic dental implants or implanted insulin pumps.
2. Patients with digital therapeutic tools such as pacemakers, implantable cardioverter-defibrillators, vagus nerve stimulators [VNS] and wearable cardioverter-defibrillators.
3. Patients with a history of seizures or uncontrolled seizures.
4. Pregnant women
5. patients with severe or recent heart disease
6. History of treatment with repetitive peripheral magnetic stimulation (rPMS)
7. Have a history of taking painkillers anti-inflammatory drugs and muscle relaxants within 24 hours
8. Have a bleeding disorder such as haemophilia or take blood-thinning medication. (anticoagulant)
9. Has a fear of needles
10. Abnormal skin conditions at the acupuncture site, such as rashes, dermatitis, or infection
11. Allergies to disinfectants used to clean the skin, such as alcohol or povidone-iodine.
12. Allergic to needles or metal
13. Allergic to adhesive plaster or Tegaderm

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
pain pressure threshold Immediately after completed of the intervention Commander Algometer

Secondary Outcome Measures

Name	Time	Method
umeric rating scale 48 hours after completed intervention pain score